Cancer Cell-derived Exosomes Induce Mitogen-activated Protein Kinase-dependent Monocyte Survival by Transport of Functional Receptor Tyrosine Kinases.

Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK. Br J Cancer (2017) 0.78

How cancer cells dictate their microenvironment: present roles of extracellular vesicles. Cell Mol Life Sci (2016) 0.75

Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36

T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (1998) 16.08

Genome engineering using the CRISPR-Cas9 system. Nat Protoc (2013) 15.98

Exosomes--vesicular carriers for intercellular communication. Curr Opin Cell Biol (2009) 6.96

Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A (2010) 6.72

Macrophage polarization comes of age. Immunity (2005) 5.67

Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol (2009) 5.44

Membrane scission by the ESCRT-III complex. Nature (2009) 4.66

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol (2009) 4.53

Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev (2006) 4.02

Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci (2010) 3.81

Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One (2010) 3.23

Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies. J Clin Oncol (2005) 2.77

Apoptotic cell removal in development and tissue homeostasis. Trends Immunol (2006) 2.51

Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell (2013) 2.49

Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol (1991) 2.39

Molecular architecture and functional model of the complete yeast ESCRT-I heterotetramer. Cell (2007) 2.21

Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol (1986) 2.04

Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J Immunol (1987) 1.95

Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer (2012) 1.92

Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol (2013) 1.88

Intracellular levels and stimulated release of lysosomal enzymes from human peripheral blood monocytes and monocyte-derived macrophages. J Reticuloendothel Soc (1980) 1.85

Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity. Am J Pathol (1983) 1.65

Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1. J Immunol (1999) 1.57

Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death. Oncogene (2003) 1.52

Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. J Biol Chem (1999) 1.51

Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics (2009) 1.49

Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. Proc Natl Acad Sci U S A (2010) 1.45

Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol (1998) 1.43

MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem (2001) 1.41

Lapatinib: a novel EGFR/HER2 tyrosine kinase inhibitor for cancer. Drugs Today (Barc) (2006) 1.40

Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses. J Biol Chem (1992) 1.38

The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J Biol Chem (2002) 1.36

ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells. Clin Cancer Res (2003) 1.35

IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol (1992) 1.24

An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein. Cancer Res (1995) 1.23

A role for the exosome in the in vivo degradation of unstable mRNAs. RNA (2003) 1.15

The molecular perspective: the ras oncogene. Oncologist (1999) 1.10

Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol (1997) 1.03

Human leptin promotes survival of human circulating blood monocytes prone to apoptosis by activation of p42/44 MAPK pathway. Cell Immunol (2002) 1.03

Monocyte survival factors induce Akt activation and suppress caspase-3. Am J Respir Cell Mol Biol (2002) 1.00

Regulation of human monocyte apoptosis by the CD14 molecule. J Immunol (1997) 0.97

Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapy. Vaccine (2002) 0.92

Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase. J Biol Chem (2001) 0.91

Expression of versican V3 by arterial smooth muscle cells alters tumor growth factor β (TGFβ)-, epidermal growth factor (EGF)-, and nuclear factor κB (NFκB)-dependent signaling pathways, creating a microenvironment that resists monocyte adhesion. J Biol Chem (2014) 0.80

Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro. J Surg Oncol (1999) 0.80

Lipopolysaccharide (LPS) modulation of human monocyte accessory cell function in promoting T-cell colonies: inability of LPS and IL-1 to abrogate the need for monocytes with high HLA-DR expression. Cell Immunol (1984) 0.79